nodes	percent_of_prediction	percent_of_DWPC	metapath
Clarithromycin—ABCB1—peripheral nervous system neoplasm	0.306	1	CbGaD
Clarithromycin—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0557	0.114	CbGbCtD
Clarithromycin—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0557	0.114	CbGbCtD
Clarithromycin—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0418	0.0854	CbGbCtD
Clarithromycin—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0334	0.0684	CbGbCtD
Clarithromycin—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0292	0.0598	CbGbCtD
Clarithromycin—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0292	0.0598	CbGbCtD
Clarithromycin—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0267	0.0546	CbGbCtD
Clarithromycin—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.0256	0.0523	CbGbCtD
Clarithromycin—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.0256	0.0523	CbGbCtD
Clarithromycin—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0203	0.0414	CbGbCtD
Clarithromycin—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0192	0.0392	CbGbCtD
Clarithromycin—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0176	0.0359	CbGbCtD
Clarithromycin—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0175	0.0358	CbGbCtD
Clarithromycin—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0163	0.0333	CbGbCtD
Clarithromycin—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0131	0.0267	CbGbCtD
Clarithromycin—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0125	0.0255	CbGbCtD
Clarithromycin—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0116	0.0238	CbGbCtD
Clarithromycin—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0114	0.0234	CbGbCtD
Clarithromycin—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0078	0.0159	CbGbCtD
Clarithromycin—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00748	0.0153	CbGbCtD
Clarithromycin—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00685	0.014	CbGbCtD
Clarithromycin—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00467	0.00955	CbGbCtD
Clarithromycin—Roxithromycin—ABCB1—peripheral nervous system neoplasm	0.000656	0.291	CrCbGaD
Clarithromycin—Azithromycin—ABCB1—peripheral nervous system neoplasm	0.000656	0.291	CrCbGaD
Clarithromycin—Troleandomycin—ABCB1—peripheral nervous system neoplasm	0.000504	0.224	CrCbGaD
Clarithromycin—Erythromycin—ABCB1—peripheral nervous system neoplasm	0.000437	0.194	CrCbGaD
Clarithromycin—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.000101	0.000499	CcSEcCtD
Clarithromycin—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	9.96e-05	0.000493	CcSEcCtD
Clarithromycin—Anorexia—Etoposide—peripheral nervous system neoplasm	9.96e-05	0.000492	CcSEcCtD
Clarithromycin—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000491	CcSEcCtD
Clarithromycin—Aspartate aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.93e-05	0.000491	CcSEcCtD
Clarithromycin—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	9.91e-05	0.00049	CcSEcCtD
Clarithromycin—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	9.88e-05	0.000488	CcSEcCtD
Clarithromycin—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	9.86e-05	0.000488	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	9.85e-05	0.000487	CcSEcCtD
Clarithromycin—Gastritis—Doxorubicin—peripheral nervous system neoplasm	9.76e-05	0.000482	CcSEcCtD
Clarithromycin—Pain—Cisplatin—peripheral nervous system neoplasm	9.75e-05	0.000482	CcSEcCtD
Clarithromycin—Alanine aminotransferase increased—Doxorubicin—peripheral nervous system neoplasm	9.73e-05	0.000481	CcSEcCtD
Clarithromycin—Dysuria—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000476	CcSEcCtD
Clarithromycin—Neutropenia—Epirubicin—peripheral nervous system neoplasm	9.63e-05	0.000476	CcSEcCtD
Clarithromycin—Asthenia—Alitretinoin—peripheral nervous system neoplasm	9.6e-05	0.000475	CcSEcCtD
Clarithromycin—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	9.59e-05	0.000474	CcSEcCtD
Clarithromycin—Asthma—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000471	CcSEcCtD
Clarithromycin—Influenza—Doxorubicin—peripheral nervous system neoplasm	9.53e-05	0.000471	CcSEcCtD
Clarithromycin—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	9.5e-05	0.00047	CcSEcCtD
Clarithromycin—Pruritus—Alitretinoin—peripheral nervous system neoplasm	9.47e-05	0.000468	CcSEcCtD
Clarithromycin—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	9.44e-05	0.000467	CcSEcCtD
Clarithromycin—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	9.4e-05	0.000465	CcSEcCtD
Clarithromycin—Paraesthesia—Etoposide—peripheral nervous system neoplasm	9.38e-05	0.000464	CcSEcCtD
Clarithromycin—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	9.34e-05	0.000462	CcSEcCtD
Clarithromycin—Dyspnoea—Etoposide—peripheral nervous system neoplasm	9.32e-05	0.000461	CcSEcCtD
Clarithromycin—Somnolence—Etoposide—peripheral nervous system neoplasm	9.29e-05	0.000459	CcSEcCtD
Clarithromycin—Asthenia—Vincristine—peripheral nervous system neoplasm	9.25e-05	0.000458	CcSEcCtD
Clarithromycin—Pneumonia—Epirubicin—peripheral nervous system neoplasm	9.24e-05	0.000457	CcSEcCtD
Clarithromycin—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000454	CcSEcCtD
Clarithromycin—Infestation—Epirubicin—peripheral nervous system neoplasm	9.18e-05	0.000454	CcSEcCtD
Clarithromycin—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.18e-05	0.000454	CcSEcCtD
Clarithromycin—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	9.16e-05	0.000453	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.00045	CcSEcCtD
Clarithromycin—Rash—Dactinomycin—peripheral nervous system neoplasm	9.1e-05	0.00045	CcSEcCtD
Clarithromycin—Decreased appetite—Etoposide—peripheral nervous system neoplasm	9.08e-05	0.000449	CcSEcCtD
Clarithromycin—Renal failure—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000446	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.02e-05	0.000446	CcSEcCtD
Clarithromycin—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	9.02e-05	0.000446	CcSEcCtD
Clarithromycin—Fatigue—Etoposide—peripheral nervous system neoplasm	9.01e-05	0.000445	CcSEcCtD
Clarithromycin—Stomatitis—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000443	CcSEcCtD
Clarithromycin—Jaundice—Epirubicin—peripheral nervous system neoplasm	8.95e-05	0.000443	CcSEcCtD
Clarithromycin—Pain—Etoposide—peripheral nervous system neoplasm	8.94e-05	0.000442	CcSEcCtD
Clarithromycin—Constipation—Etoposide—peripheral nervous system neoplasm	8.94e-05	0.000442	CcSEcCtD
Clarithromycin—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	8.93e-05	0.000441	CcSEcCtD
Clarithromycin—Dysuria—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000441	CcSEcCtD
Clarithromycin—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	8.91e-05	0.000441	CcSEcCtD
Clarithromycin—Dizziness—Alitretinoin—peripheral nervous system neoplasm	8.85e-05	0.000438	CcSEcCtD
Clarithromycin—Diarrhoea—Vincristine—peripheral nervous system neoplasm	8.83e-05	0.000436	CcSEcCtD
Clarithromycin—Haematuria—Epirubicin—peripheral nervous system neoplasm	8.76e-05	0.000433	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Epirubicin—peripheral nervous system neoplasm	8.69e-05	0.000429	CcSEcCtD
Clarithromycin—Epistaxis—Epirubicin—peripheral nervous system neoplasm	8.66e-05	0.000428	CcSEcCtD
Clarithromycin—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	8.61e-05	0.000426	CcSEcCtD
Clarithromycin—Nausea—Dactinomycin—peripheral nervous system neoplasm	8.58e-05	0.000424	CcSEcCtD
Clarithromycin—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	8.57e-05	0.000424	CcSEcCtD
Clarithromycin—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	8.55e-05	0.000423	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	8.54e-05	0.000422	CcSEcCtD
Clarithromycin—Dizziness—Vincristine—peripheral nervous system neoplasm	8.53e-05	0.000422	CcSEcCtD
Clarithromycin—Vomiting—Alitretinoin—peripheral nervous system neoplasm	8.51e-05	0.000421	CcSEcCtD
Clarithromycin—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.00042	CcSEcCtD
Clarithromycin—Infestation—Doxorubicin—peripheral nervous system neoplasm	8.5e-05	0.00042	CcSEcCtD
Clarithromycin—Rash—Alitretinoin—peripheral nervous system neoplasm	8.44e-05	0.000417	CcSEcCtD
Clarithromycin—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	8.43e-05	0.000417	CcSEcCtD
Clarithromycin—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000417	CcSEcCtD
Clarithromycin—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	8.4e-05	0.000415	CcSEcCtD
Clarithromycin—Headache—Alitretinoin—peripheral nervous system neoplasm	8.39e-05	0.000415	CcSEcCtD
Clarithromycin—Renal failure—Doxorubicin—peripheral nervous system neoplasm	8.35e-05	0.000413	CcSEcCtD
Clarithromycin—Urticaria—Etoposide—peripheral nervous system neoplasm	8.3e-05	0.00041	CcSEcCtD
Clarithromycin—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.00041	CcSEcCtD
Clarithromycin—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.00041	CcSEcCtD
Clarithromycin—Jaundice—Doxorubicin—peripheral nervous system neoplasm	8.28e-05	0.00041	CcSEcCtD
Clarithromycin—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000409	CcSEcCtD
Clarithromycin—Body temperature increased—Etoposide—peripheral nervous system neoplasm	8.26e-05	0.000408	CcSEcCtD
Clarithromycin—Abdominal pain—Etoposide—peripheral nervous system neoplasm	8.26e-05	0.000408	CcSEcCtD
Clarithromycin—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	8.26e-05	0.000408	CcSEcCtD
Clarithromycin—Hepatitis—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000408	CcSEcCtD
Clarithromycin—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000408	CcSEcCtD
Clarithromycin—Vomiting—Vincristine—peripheral nervous system neoplasm	8.2e-05	0.000405	CcSEcCtD
Clarithromycin—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.18e-05	0.000405	CcSEcCtD
Clarithromycin—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	8.18e-05	0.000405	CcSEcCtD
Clarithromycin—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	8.14e-05	0.000403	CcSEcCtD
Clarithromycin—Rash—Vincristine—peripheral nervous system neoplasm	8.13e-05	0.000402	CcSEcCtD
Clarithromycin—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.13e-05	0.000402	CcSEcCtD
Clarithromycin—Haematuria—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000401	CcSEcCtD
Clarithromycin—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	8.1e-05	0.000401	CcSEcCtD
Clarithromycin—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	8.08e-05	0.0004	CcSEcCtD
Clarithromycin—Headache—Vincristine—peripheral nervous system neoplasm	8.08e-05	0.0004	CcSEcCtD
Clarithromycin—Hepatobiliary disease—Doxorubicin—peripheral nervous system neoplasm	8.04e-05	0.000397	CcSEcCtD
Clarithromycin—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	8.01e-05	0.000396	CcSEcCtD
Clarithromycin—Nausea—Alitretinoin—peripheral nervous system neoplasm	7.95e-05	0.000393	CcSEcCtD
Clarithromycin—Visual impairment—Epirubicin—peripheral nervous system neoplasm	7.94e-05	0.000393	CcSEcCtD
Clarithromycin—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	7.93e-05	0.000392	CcSEcCtD
Clarithromycin—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	7.8e-05	0.000386	CcSEcCtD
Clarithromycin—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	7.8e-05	0.000385	CcSEcCtD
Clarithromycin—Eye disorder—Epirubicin—peripheral nervous system neoplasm	7.7e-05	0.000381	CcSEcCtD
Clarithromycin—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	7.7e-05	0.000381	CcSEcCtD
Clarithromycin—Tinnitus—Epirubicin—peripheral nervous system neoplasm	7.69e-05	0.00038	CcSEcCtD
Clarithromycin—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000379	CcSEcCtD
Clarithromycin—Nausea—Vincristine—peripheral nervous system neoplasm	7.66e-05	0.000379	CcSEcCtD
Clarithromycin—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000378	CcSEcCtD
Clarithromycin—Flushing—Epirubicin—peripheral nervous system neoplasm	7.65e-05	0.000378	CcSEcCtD
Clarithromycin—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000378	CcSEcCtD
Clarithromycin—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000377	CcSEcCtD
Clarithromycin—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	7.63e-05	0.000377	CcSEcCtD
Clarithromycin—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	7.57e-05	0.000374	CcSEcCtD
Clarithromycin—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000372	CcSEcCtD
Clarithromycin—Asthenia—Etoposide—peripheral nervous system neoplasm	7.5e-05	0.000371	CcSEcCtD
Clarithromycin—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000371	CcSEcCtD
Clarithromycin—Angiopathy—Epirubicin—peripheral nervous system neoplasm	7.48e-05	0.00037	CcSEcCtD
Clarithromycin—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	7.48e-05	0.00037	CcSEcCtD
Clarithromycin—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	7.45e-05	0.000368	CcSEcCtD
Clarithromycin—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	7.43e-05	0.000367	CcSEcCtD
Clarithromycin—Chills—Epirubicin—peripheral nervous system neoplasm	7.4e-05	0.000366	CcSEcCtD
Clarithromycin—Pruritus—Etoposide—peripheral nervous system neoplasm	7.39e-05	0.000365	CcSEcCtD
Clarithromycin—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.35e-05	0.000363	CcSEcCtD
Clarithromycin—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.25e-05	0.000359	CcSEcCtD
Clarithromycin—Mental disorder—Epirubicin—peripheral nervous system neoplasm	7.22e-05	0.000357	CcSEcCtD
Clarithromycin—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	7.21e-05	0.000357	CcSEcCtD
Clarithromycin—Rash—Cisplatin—peripheral nervous system neoplasm	7.19e-05	0.000356	CcSEcCtD
Clarithromycin—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.18e-05	0.000355	CcSEcCtD
Clarithromycin—Malnutrition—Epirubicin—peripheral nervous system neoplasm	7.18e-05	0.000355	CcSEcCtD
Clarithromycin—Diarrhoea—Etoposide—peripheral nervous system neoplasm	7.15e-05	0.000353	CcSEcCtD
Clarithromycin—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.13e-05	0.000352	CcSEcCtD
Clarithromycin—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.11e-05	0.000352	CcSEcCtD
Clarithromycin—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.00035	CcSEcCtD
Clarithromycin—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.08e-05	0.00035	CcSEcCtD
Clarithromycin—Flatulence—Epirubicin—peripheral nervous system neoplasm	7.07e-05	0.00035	CcSEcCtD
Clarithromycin—Tension—Epirubicin—peripheral nervous system neoplasm	7.04e-05	0.000348	CcSEcCtD
Clarithromycin—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.03e-05	0.000347	CcSEcCtD
Clarithromycin—Nervousness—Epirubicin—peripheral nervous system neoplasm	6.97e-05	0.000345	CcSEcCtD
Clarithromycin—Back pain—Epirubicin—peripheral nervous system neoplasm	6.94e-05	0.000343	CcSEcCtD
Clarithromycin—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	6.92e-05	0.000342	CcSEcCtD
Clarithromycin—Dizziness—Etoposide—peripheral nervous system neoplasm	6.91e-05	0.000342	CcSEcCtD
Clarithromycin—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	6.9e-05	0.000341	CcSEcCtD
Clarithromycin—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	6.89e-05	0.000341	CcSEcCtD
Clarithromycin—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	6.87e-05	0.00034	CcSEcCtD
Clarithromycin—Chills—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000338	CcSEcCtD
Clarithromycin—Nausea—Cisplatin—peripheral nervous system neoplasm	6.77e-05	0.000335	CcSEcCtD
Clarithromycin—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	6.68e-05	0.00033	CcSEcCtD
Clarithromycin—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	6.66e-05	0.000329	CcSEcCtD
Clarithromycin—Vomiting—Etoposide—peripheral nervous system neoplasm	6.64e-05	0.000328	CcSEcCtD
Clarithromycin—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	6.64e-05	0.000328	CcSEcCtD
Clarithromycin—Anaemia—Epirubicin—peripheral nervous system neoplasm	6.63e-05	0.000328	CcSEcCtD
Clarithromycin—Agitation—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000326	CcSEcCtD
Clarithromycin—Rash—Etoposide—peripheral nervous system neoplasm	6.59e-05	0.000326	CcSEcCtD
Clarithromycin—Dermatitis—Etoposide—peripheral nervous system neoplasm	6.58e-05	0.000325	CcSEcCtD
Clarithromycin—Headache—Etoposide—peripheral nervous system neoplasm	6.55e-05	0.000324	CcSEcCtD
Clarithromycin—Flatulence—Doxorubicin—peripheral nervous system neoplasm	6.54e-05	0.000324	CcSEcCtD
Clarithromycin—Tension—Doxorubicin—peripheral nervous system neoplasm	6.52e-05	0.000322	CcSEcCtD
Clarithromycin—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000322	CcSEcCtD
Clarithromycin—Malaise—Epirubicin—peripheral nervous system neoplasm	6.47e-05	0.00032	CcSEcCtD
Clarithromycin—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.45e-05	0.000319	CcSEcCtD
Clarithromycin—Vertigo—Epirubicin—peripheral nervous system neoplasm	6.45e-05	0.000319	CcSEcCtD
Clarithromycin—Leukopenia—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000318	CcSEcCtD
Clarithromycin—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.42e-05	0.000318	CcSEcCtD
Clarithromycin—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	6.38e-05	0.000316	CcSEcCtD
Clarithromycin—Palpitations—Epirubicin—peripheral nervous system neoplasm	6.34e-05	0.000314	CcSEcCtD
Clarithromycin—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000312	CcSEcCtD
Clarithromycin—Cough—Epirubicin—peripheral nervous system neoplasm	6.26e-05	0.00031	CcSEcCtD
Clarithromycin—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.22e-05	0.000307	CcSEcCtD
Clarithromycin—Nausea—Etoposide—peripheral nervous system neoplasm	6.21e-05	0.000307	CcSEcCtD
Clarithromycin—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000305	CcSEcCtD
Clarithromycin—Anaemia—Doxorubicin—peripheral nervous system neoplasm	6.14e-05	0.000303	CcSEcCtD
Clarithromycin—Myalgia—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000302	CcSEcCtD
Clarithromycin—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.11e-05	0.000302	CcSEcCtD
Clarithromycin—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.1e-05	0.000302	CcSEcCtD
Clarithromycin—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.09e-05	0.000301	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	6.07e-05	0.0003	CcSEcCtD
Clarithromycin—Discomfort—Epirubicin—peripheral nervous system neoplasm	6.04e-05	0.000298	CcSEcCtD
Clarithromycin—Malaise—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000296	CcSEcCtD
Clarithromycin—Dry mouth—Epirubicin—peripheral nervous system neoplasm	5.98e-05	0.000295	CcSEcCtD
Clarithromycin—Vertigo—Doxorubicin—peripheral nervous system neoplasm	5.97e-05	0.000295	CcSEcCtD
Clarithromycin—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000294	CcSEcCtD
Clarithromycin—Confusional state—Epirubicin—peripheral nervous system neoplasm	5.91e-05	0.000292	CcSEcCtD
Clarithromycin—Palpitations—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.00029	CcSEcCtD
Clarithromycin—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	5.86e-05	0.00029	CcSEcCtD
Clarithromycin—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000289	CcSEcCtD
Clarithromycin—Infection—Epirubicin—peripheral nervous system neoplasm	5.82e-05	0.000288	CcSEcCtD
Clarithromycin—Cough—Doxorubicin—peripheral nervous system neoplasm	5.79e-05	0.000286	CcSEcCtD
Clarithromycin—Convulsion—Doxorubicin—peripheral nervous system neoplasm	5.75e-05	0.000284	CcSEcCtD
Clarithromycin—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	5.74e-05	0.000284	CcSEcCtD
Clarithromycin—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	5.73e-05	0.000284	CcSEcCtD
Clarithromycin—Skin disorder—Epirubicin—peripheral nervous system neoplasm	5.69e-05	0.000281	CcSEcCtD
Clarithromycin—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.00028	CcSEcCtD
Clarithromycin—Myalgia—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.00028	CcSEcCtD
Clarithromycin—Chest pain—Doxorubicin—peripheral nervous system neoplasm	5.65e-05	0.00028	CcSEcCtD
Clarithromycin—Anxiety—Doxorubicin—peripheral nervous system neoplasm	5.63e-05	0.000279	CcSEcCtD
Clarithromycin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	5.61e-05	0.000278	CcSEcCtD
Clarithromycin—Discomfort—Doxorubicin—peripheral nervous system neoplasm	5.59e-05	0.000276	CcSEcCtD
Clarithromycin—Anorexia—Epirubicin—peripheral nervous system neoplasm	5.58e-05	0.000276	CcSEcCtD
Clarithromycin—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	5.53e-05	0.000273	CcSEcCtD
Clarithromycin—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.46e-05	0.00027	CcSEcCtD
Clarithromycin—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.42e-05	0.000268	CcSEcCtD
Clarithromycin—Infection—Doxorubicin—peripheral nervous system neoplasm	5.38e-05	0.000266	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	5.34e-05	0.000264	CcSEcCtD
Clarithromycin—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000263	CcSEcCtD
Clarithromycin—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	5.31e-05	0.000262	CcSEcCtD
Clarithromycin—Insomnia—Epirubicin—peripheral nervous system neoplasm	5.3e-05	0.000262	CcSEcCtD
Clarithromycin—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	5.26e-05	0.00026	CcSEcCtD
Clarithromycin—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.26e-05	0.00026	CcSEcCtD
Clarithromycin—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000259	CcSEcCtD
Clarithromycin—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.22e-05	0.000258	CcSEcCtD
Clarithromycin—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.21e-05	0.000257	CcSEcCtD
Clarithromycin—Anorexia—Doxorubicin—peripheral nervous system neoplasm	5.17e-05	0.000255	CcSEcCtD
Clarithromycin—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	5.16e-05	0.000255	CcSEcCtD
Clarithromycin—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	5.09e-05	0.000252	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.06e-05	0.00025	CcSEcCtD
Clarithromycin—Fatigue—Epirubicin—peripheral nervous system neoplasm	5.05e-05	0.00025	CcSEcCtD
Clarithromycin—Pain—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000248	CcSEcCtD
Clarithromycin—Constipation—Epirubicin—peripheral nervous system neoplasm	5.01e-05	0.000248	CcSEcCtD
Clarithromycin—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	4.94e-05	0.000244	CcSEcCtD
Clarithromycin—Insomnia—Doxorubicin—peripheral nervous system neoplasm	4.9e-05	0.000242	CcSEcCtD
Clarithromycin—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	4.87e-05	0.000241	CcSEcCtD
Clarithromycin—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	4.83e-05	0.000239	CcSEcCtD
Clarithromycin—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	4.83e-05	0.000239	CcSEcCtD
Clarithromycin—Somnolence—Doxorubicin—peripheral nervous system neoplasm	4.82e-05	0.000238	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	4.79e-05	0.000237	CcSEcCtD
Clarithromycin—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	4.77e-05	0.000236	CcSEcCtD
Clarithromycin—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	4.71e-05	0.000233	CcSEcCtD
Clarithromycin—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	4.68e-05	0.000231	CcSEcCtD
Clarithromycin—Fatigue—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000231	CcSEcCtD
Clarithromycin—Urticaria—Epirubicin—peripheral nervous system neoplasm	4.65e-05	0.00023	CcSEcCtD
Clarithromycin—Constipation—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000229	CcSEcCtD
Clarithromycin—Pain—Doxorubicin—peripheral nervous system neoplasm	4.63e-05	0.000229	CcSEcCtD
Clarithromycin—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000229	CcSEcCtD
Clarithromycin—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	4.63e-05	0.000229	CcSEcCtD
Clarithromycin—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.47e-05	0.000221	CcSEcCtD
Clarithromycin—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	4.43e-05	0.000219	CcSEcCtD
Clarithromycin—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.32e-05	0.000213	CcSEcCtD
Clarithromycin—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.31e-05	0.000213	CcSEcCtD
Clarithromycin—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000212	CcSEcCtD
Clarithromycin—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	4.28e-05	0.000212	CcSEcCtD
Clarithromycin—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000208	CcSEcCtD
Clarithromycin—Pruritus—Epirubicin—peripheral nervous system neoplasm	4.14e-05	0.000205	CcSEcCtD
Clarithromycin—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	4.01e-05	0.000198	CcSEcCtD
Clarithromycin—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	3.99e-05	0.000197	CcSEcCtD
Clarithromycin—Asthenia—Doxorubicin—peripheral nervous system neoplasm	3.89e-05	0.000192	CcSEcCtD
Clarithromycin—Dizziness—Epirubicin—peripheral nervous system neoplasm	3.87e-05	0.000191	CcSEcCtD
Clarithromycin—Pruritus—Doxorubicin—peripheral nervous system neoplasm	3.83e-05	0.00019	CcSEcCtD
Clarithromycin—Vomiting—Epirubicin—peripheral nervous system neoplasm	3.72e-05	0.000184	CcSEcCtD
Clarithromycin—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	3.71e-05	0.000183	CcSEcCtD
Clarithromycin—Rash—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000183	CcSEcCtD
Clarithromycin—Dermatitis—Epirubicin—peripheral nervous system neoplasm	3.69e-05	0.000182	CcSEcCtD
Clarithromycin—Headache—Epirubicin—peripheral nervous system neoplasm	3.67e-05	0.000181	CcSEcCtD
Clarithromycin—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.58e-05	0.000177	CcSEcCtD
Clarithromycin—Nausea—Epirubicin—peripheral nervous system neoplasm	3.48e-05	0.000172	CcSEcCtD
Clarithromycin—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.45e-05	0.00017	CcSEcCtD
Clarithromycin—Rash—Doxorubicin—peripheral nervous system neoplasm	3.42e-05	0.000169	CcSEcCtD
Clarithromycin—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.41e-05	0.000169	CcSEcCtD
Clarithromycin—Headache—Doxorubicin—peripheral nervous system neoplasm	3.4e-05	0.000168	CcSEcCtD
Clarithromycin—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.22e-05	0.000159	CcSEcCtD
